Back to Jane Street Group, LLC Jane Street Group, LLC

AKTXAKTX

2 quarters

Position history for Jane Street Group, LLCJane Street Group, LLC's holdings in Akari Therapeutics Plc

No. Jane Street Group exited its AKTX (Akari Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 71,644 shares worth $20,705. Jane Street Group first reported AKTX in Q4 2025 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$20,705

Total Shares Change

-71,644

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$5.15
0
2025-Q4
New
71,644
—
$20,7050.0%$11.56
29

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used